NL-OMON41290尚未招募不适用
Contrast-enhanced MR imaging of ductal carcinoma in-situ/invasive lobular carcinoma in supine position: a pilot study - Supine contrast enhanced MRI of DCIS/ILC
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Histological proven invasive breast cancer with a DCIS (component) or pure ILC
- •Schedule for breast conserving therapy
- •A diagnositic contrast enhance MRI in prone position
- •Informed consent
- •><= 18 years old
排除标准
- •Contra indication for MRI
- •Contra indication for gadolinium contrast administration
研究者
相似试验
已完成
不适用
Contrast-enhanced MR imaging of the breast at 7T and 3T in the same patients.breast neoplasm10006291breast cancerNL-OMON40016niversitair Medisch Centrum Utrecht60
尚未招募
不适用
Contrast-enhanced MR imaging of the breast at 7T and 3T in the same patients.breast cancer, breast neoplasiaNL-OMON27773niversity Medical Center Utrecht (UMCU)60
已完成
不适用
Contrast enhanced Magnetic Resonance Imaging of the lungs in children with Cystic Fibrosis.10038716mucoviscoidosisNL-OMON31207Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
不适用
MR imaging of endometrial carcinoma for preoperative staging: a prospective studyJPRN-UMIN000003054Osaka University50
进行中（未招募）
1 期
Dynamic contrast enhanced MRI (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-a in patients with advanced renal cell carcinoma. - DCE-MRI changes in tumour vaculature with Bevacizumab and Interferon in advanced RCCPreviously untreated metastatic (stage IV) or locally advanced (inoperable stage III), renal cell carcinomaMedDRA version: 9.1Level: HLTClassification code 10038408Term: Renal cell carcinomasEUCTR2008-006414-19-GBEast and North Hertfordhsire NHS Trust30